Authors' reply to Adam and to Veal and Thompson

Affiliations

¹ George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia gmachado@georgeinstitute.org.au.
² George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia.

Comment

Gustavo C Machado et al. BMJ. 2015.

. 2015 Apr 28:350:h2223.

doi: 10.1136/bmj.h2223.

¹ George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia gmachado@georgeinstitute.org.au.
² George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia.

No abstract available

Comment on

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.
Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CW, Day RO, McLachlan AJ, Ferreira ML. Machado GC, et al. BMJ. 2015 Mar 31;350:h1225. doi: 10.1136/bmj.h1225. BMJ. 2015. PMID: 25828856 Free PMC article.
Danger of generalising findings on paracetamol for low back pain.
Adam R. Adam R. BMJ. 2015 Apr 28;350:h2220. doi: 10.1136/bmj.h2220. BMJ. 2015. PMID: 25920321 No abstract available.
Paracetamol should remain the first line option for persistent pain.
Veal FC, Thompson AJ. Veal FC, et al. BMJ. 2015 Apr 28;350:h2221. doi: 10.1136/bmj.h2221. BMJ. 2015. PMID: 25922188 No abstract available.